Biotechnology / Medical Research
3SBio Inc. Reiterates FY 2012 Revenue Guidance
3SBio Inc. reiterated fiscal 2012 net revenues guidance of USD99-USD108 million.
Arno Therapeutics Inc Announces Orphan-Drug Designation For AR-42 In Europe
Arno Therapeutics Inc announced that its investigational compound known as AR-42 has been granted orphan-drug designation by the European Medicines Agency’s (EMA) Committee for Orphan Medicinal Products for the treatment of neurofibromatosis type 2 (NF2). NF2 is a rare genetic disorder characterized...
Malaysian Genomics Resource Centre Bhd Acquires 50% Equity Interest In MPath Sdn Bhd
Malaysian Genomics Resource Centre Bhd (MGRC) announced that it has acquired one ordinary share of MYR 1.00, representing 50% equity interest in MPath Sdn Bhd (MPATH) for a cash consideration of MYR 1.00.
Pronova Biopharma ASA Maintains FY 2012 Revenue and EBITDA Guidance
Pronova Biopharma ASA announced that it has maintained its outlook for the fiscal year 2012 with revenue and EBITDA growth. The main risk to the outlook is loss of market exclusivity. According to I/B/E/S Estimates, analysts are expecting the Company to report fiscal year 2012 revenue of NOK...
Mergers & Acquisitions
- Malaysian Genomics Resource Centre Bhd Acquires 50% Equity Interest In MPath Sdn Bhd
- Spectrum Pharmaceuticals Inc And Allos Therapeutics, Inc. Announce Extension Of Previously Announced Tender Offer For Shares Of Allos Therapeutics, Inc.
- GlaxoSmithKline plc To Commence Tender Offer To Acquire Human Genome Sciences Inc For USD13.00 Per Share In Cash
Markets
- Sectors
- Europe
- U.S.
- Asia
Sector Summary
| Energy |  -0.71% |
| Basic Materials | -1.19% |
| Industrials | -0.41% |
| Cyclical Goods & Services | -0.54% |
| Non-Cyclical Goods & Services | -0.44% |
| Financials | -0.56% |
| Healthcare | -0.46% |
| Technology | -0.14% |
| Telecoms | -0.38% |
| Utilities | -0.30% |
| DOW | 12,820.60 | -34.44 |
-0.27% |
| S&P; 500 | 1,353.39 | -4.60 |
-0.34% |
| NASDAQ | 2,933.82 |  +0.18 |
+0.01% |
| TR US Index | 122.94 | -0.36 |
-0.29% |
Upcoming Events
No related earnings announcements are currently scheduled within the next 7 days.
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and
